Nomura Holdings Inc Bausch Health Companies Inc. Transaction History

Nomura Holdings Inc

$47 Billion
Q1 2025

A detailed history of Nomura Holdings Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 23,395,000 shares of BHC stock, worth $106 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

23,395,000

Previous 11,345,000 106.21%

Holding current value

$106 Million

Previous $91.4 Million 65.53%

% of portfolio

0.32%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$6.16 - $7.94 $74.2 Million - $95.7 Million	12,050,000 Added 106.21%	23,395,000 $151 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $41.9 Million - $66.3 Million	-8,025,000 Reduced 41.43%	11,345,000 $92.5 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $24.4 Million - $41.6 Million	4,000,000 Added 26.02%	19,370,000 $135 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $10.61 $119 Million - $163 Million	15,370,000 New	15,370,000 $163 Million
Q4 2023 Feb 14, 2024	SELL	$6.53 - $8.23 $31.3 Million - $39.4 Million	-4,790,000 Reduced 26.48%	13,296,000 $107 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $52.3 Million - $66.1 Million	6,803,015 Added 60.29%	18,086,000 $149 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $34.3 Million - $52.7 Million	5,992,459 Added 113.27%	11,282,985 $90.3 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $41 Million - $64.3 Million	-6,531,826 Reduced 55.25%	5,290,526 $42.9 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $28.4 Million - $37 Million	-4,666,399 Reduced 28.3%	11,822,352 $74.1 Million
Q3 2022 Nov 15, 2022	BUY	$4.58 - $9.21 $14.4 Million - $28.9 Million	3,134,443 Added 23.47%	16,488,751 $114 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $35.4 Million - $119 Million	-5,019,076 Reduced 27.32%	13,354,308 $114 Million
Q1 2022 May 18, 2022	SELL	$21.6 - $27.79 $13.3 Million - $17.1 Million	-616,695 Reduced 3.25%	18,373,384 $424 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $83.1 Million - $105 Million	3,611,646 Added 23.49%	18,990,079 $524 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $250 Million - $300 Million	9,987,706 Added 185.28%	15,378,433 $440 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $145 Million - $173 Million	5,280,727 Added 4800.66%	5,390,727 $158 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $2.35 Million - $3.78 Million	110,000 New	110,000 $3.49 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $1.22 Million - $1.69 Million	-80,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$14.88 - $20.13 $1.01 Million - $1.37 Million	68,000 Added 566.67%	80,000 $1.24 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $46.5 Million - $71.6 Million	-3,492,245 Reduced 99.66%	12,000 $219,000
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $9.55 Million - $22.2 Million	735,500 Added 26.56%	3,504,245 $54.3 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $142,543 - $240,641	-7,546 Reduced 0.27%	2,768,745 $82.8 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $10.3 Million - $12.7 Million	493,103 Added 21.6%	2,776,291 $55 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $71.6 Million - $92.3 Million	-3,488,152 Reduced 60.44%	2,283,188 $57.2 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $18 Million - $23.3 Million	-887,332 Reduced 13.33%	5,771,340 $144 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $14.6 Million - $23.4 Million	827,232 Added 14.19%	6,658,672 $123 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $120 Million - $150 Million	5,831,440 New	5,831,440 $159 Million

Others Institutions Holding BHC

# of Institutions

271

Shares Held

243M

Call Options Held

3.66M

Put Options Held

11.3M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.64B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Bausch Health Companies Inc. Transaction History